Copyright: ©Author(s) 2026.
World J Clin Pediatr. Sep 9, 2026; 15(3): 118321
Published online Sep 9, 2026. doi: 10.5409/wjcp.118321
Published online Sep 9, 2026. doi: 10.5409/wjcp.118321
Table 1 Demographic data of study population, n (%)
| Total (n = 36) | GA (n = 18) | TA (n = 18) | P value | |
| Females | 17 (47.2) | 12 (66.7) | 5 (27.8) | 0.044 |
| Males | 19 (52.8) | 6 (33.3) | 13 (72.2) | 0.044 |
| ANH | 12 (33.3) | 9 (50) | 3 (16.7) | 0.151 |
| SQUH | 8 (22.2) | 5 (27.8) | 3 (16.7) | 0.151 |
| Others | 16 (44.4) | 4 (22.2) | 12 (66.7) | 0.151 |
| Gestational age (weeks), mean (SD) | Not applicable | 27.18 (2.4) | 25.13 (1.6) | 0.020 |
| Birth weight (kg), mean (SD) | Not applicable | 0.99 (0.25) | 0.71 (0.14) | 0.004 |
Table 2 Primary outcome and clinical parameters 48 hours post-procedure, n (%)
| GA | TA | P value | |
| Episodes of apnea | 3 (16.6) | 1(5.6) | 0.601 |
| Need for oxygen 48 hours post-procedure | 5 (27.8) | 1 (5.6) | 0.177 |
| Need for respiratory support 48 hours post procedure | 5 (27.8) | 0 (0.0) | 0.045 |
| RR (breath/minute), mean (SD) | 42.5 (10.8) | 47 (6.7) | 0.187 |
| HR (beat/minute), mean (SD) | 144.8 (9.0) | 150 (10.1) | 0.771 |
| Syst. p(B) (mmHg), mean (SD) | 80.3 (7.5) | 77.9 (13.6) | 0.046 |
| Dia. P(B) (mmHg), mean (SD) | 41.3 (5.9) | 50 (17.3) | 0.001 |
| Oxygen saturation (%), mean (SD) | 98.4 (2.1) | 96.8 (2.5) | 0.443 |
Table 3 Risk ratio between two groups
| Topical anesthesia | General anesthesia | Total | |
| Adverse outcome (+) | 1 | 5 | 6 |
| Adverse outcome (-) | 17 | 13 | 30 |
| Total | 18 | 18 | 36 |
| Risk in TA (R1) | 1/18 = 0.05 | ||
| Risk in GA (R0) | 5/18 = 0.28 | ||
| Risk difference | 0.05-0.28 = -0.23 | ||
| Risk ratio | 0.05/0.28 = 0.18 |
Table 4 Summary of list of items considered in the cost calculation of each type of procedures
| General anesthesia | Topical anesthesia | |
| Pre-op | Medication (Lucentis) | Medication (Lucentis) |
| Anesthesia consultation +/- any subspeciality asked by anesthesia | ||
| Intra-op | Anesthesia doctor + anesthesia nurse + medications + instruments | NICU staff |
| OR nurse/ophthalmic | NICU nurse | |
| Surgeon | Surgeon | |
| Shifting patient from the ward to OR | ||
| OR time 30-60 minutes | ||
| Post-op | Post-op recovery | NICU nurse observation |
| Shifting from OR to ward |
Table 5 Summary of the cost of each stage of the procedure in the general anesthesia group
| GA | Cost | |
| Pre-op | Anesthesia consultation +/- any subspeciality asked by anesthesia | 130 $ |
| Intra-op | Anesthesia doctor + medications + instruments | 390 $ |
| OR time 30-60 minutes | 2150 $ | |
| Post-op | Post-op recovery | 52 $ |
| Total | 2722 $ | |
- Citation: Al Habsi AA, Al Mandhari HK, Ganesh AS, Al Zuhaibi SS, Al Habsi NS, Al-Farsi NH. Systemic outcomes of anesthesia method in anti-vascular endothelial growth factor therapy for retinopathy of prematurity: General vs topical. World J Clin Pediatr 2026; 15(3): 118321
- URL: https://www.wjgnet.com/2219-2808/full/v15/i3/118321.htm
- DOI: https://dx.doi.org/10.5409/wjcp.118321